Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Neharika Jain

FORGOTTEN HISTORY: What are wall street analysts target price for edwards lifesciences stock | History Defined

Valued at a market cap of $45.7 billion, Edwards Lifesciences Corporation (EW) provides products and technologies to treat advanced cardiovascular diseases. The Irvine, California-based company is known for its patient-centric approach and close collaboration with physicians. 

This healthcare company has underperformed the broader market over the past 52 weeks. Shares of EW have gained 10.9% over this time frame, while the broader S&P 500 Index ($SPX) has soared 14%. Moreover, on a YTD basis, the stock is down 7.7%, compared to SPX’s 1.3% return.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.